A novel humanized immune stroma PDX cancer model for therapeutic studies
Abstract Standard preclinical human tumor models lack a human tumor stroma. However, as stroma contributes to therapeutic resistance, the lack of human stroma may make current models less stringent for testing new therapies. To address this, using patient-derived tumor cells, patient-derived cancer-...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Springer
2026-03-01
|
| Sraith: | Cancer Immunology, Immunotherapy |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1007/s00262-026-04349-4 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
